Valérie D. P.
- Country
- France
- Department
- Service de Rhumatologie
Research Overview
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Long-term Safety and Efficacy Assessment of Ianalumab in Sjögren’s Syndrome: A Randomized, Double-blind, Two-arm NEPTUNUS Extension Study
Data & Insights
Has run more than one trial at 161 of 309 partner sites.
Specializations
Sjögren's Syndrome Research
The investigator specializes in studying primary and secondary Sjögren's syndrome, with particular focus on novel therapeutic approaches and disease management strategies.
- Systemic Disease Activity Assessment
- Long-term Treatment Efficacy
- Innovative Biologic Therapies
Their research extends to peripheral neuropathy complications associated with Sjögren's syndrome and immunoglobulin-based treatments.
Autoimmune Disease Management
The investigator focuses on complex autoimmune disorders, including severe manifestations requiring targeted therapeutic interventions.
- Disease Activity Monitoring
- Immunomodulatory Treatments
- Combined Therapy Approaches
Their work includes evaluation of novel biological agents and their effects on systemic disease manifestations.
Giant Cell Arteritis Studies
The investigator conducts research in giant cell arteritis treatment, exploring various therapeutic options and management strategies.
- Treatment Discontinuation Protocols
- Comparative Treatment Studies
- Glucocorticoid Tapering Regimens
Their research includes evaluation of long-term disease control and treatment optimization methods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.